Zarrinkar PP - Search Results

1

Unique fatty acid composition of normal cartilage: discovery of high levels of n-9 eicosatrienoic acid and low levels of n-6 polyunsaturated fatty acids.

Adkisson HD 4th, Risener FS Jr, Zarrinkar PP, Walla MD, Christie WW, Wuthier RE. Adkisson HD 4th, et al. Among authors: zarrinkar pp. FASEB J. 1991 Mar 1;5(3):344-53. doi: 10.1096/fasebj.5.3.2001795. FASEB J. 1991. PMID: 2001795

2

Kinetic intermediates in RNA folding.

Zarrinkar PP, Williamson JR. Zarrinkar PP, et al. Science. 1994 Aug 12;265(5174):918-24. doi: 10.1126/science.8052848. Science. 1994. PMID: 8052848

3

The kinetic folding pathway of the Tetrahymena ribozyme reveals possible similarities between RNA and protein folding.

Zarrinkar PP, Williamson JR. Zarrinkar PP, et al. Nat Struct Biol. 1996 May;3(5):432-8. doi: 10.1038/nsb0596-432. Nat Struct Biol. 1996. PMID: 8612073

4

Slow folding kinetics of RNase P RNA.

Zarrinkar PP, Wang J, Williamson JR. Zarrinkar PP, et al. RNA. 1996 Jun;2(6):564-73. RNA. 1996. PMID: 8718685 Free PMC article.

5

High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors.

Miduturu CV, Deng X, Kwiatkowski N, Yang W, Brault L, Filippakopoulos P, Chung E, Yang Q, Schwaller J, Knapp S, King RW, Lee JD, Herrgard S, Zarrinkar P, Gray NS. Miduturu CV, et al. Chem Biol. 2011 Jul 29;18(7):868-79. doi: 10.1016/j.chembiol.2011.05.010. Chem Biol. 2011. PMID: 21802008 Free PMC article.

6

The P9.1-P9.2 peripheral extension helps guide folding of the Tetrahymena ribozyme.

Zarrinkar PP, Williamson JR. Zarrinkar PP, et al. Nucleic Acids Res. 1996 Mar 1;24(5):854-8. doi: 10.1093/nar/24.5.854. Nucleic Acids Res. 1996. PMID: 8600452 Free PMC article.

7

Kinetic intermediates trapped by native interactions in RNA folding.

Treiber DK, Rook MS, Zarrinkar PP, Williamson JR. Treiber DK, et al. Among authors: zarrinkar pp. Science. 1998 Mar 20;279(5358):1943-6. doi: 10.1126/science.279.5358.1943. Science. 1998. PMID: 9506945

8

Optimizing the substrate specificity of a group I intron ribozyme.

Zarrinkar PP, Sullenger BA. Zarrinkar PP, et al. Biochemistry. 1999 Mar 16;38(11):3426-32. doi: 10.1021/bi982688m. Biochemistry. 1999. PMID: 10079089

9

High-throughput kinase profiling as a platform for drug discovery.

Goldstein DM, Gray NS, Zarrinkar PP. Goldstein DM, et al. Among authors: zarrinkar pp. Nat Rev Drug Discov. 2008 May;7(5):391-7. doi: 10.1038/nrd2541. Nat Rev Drug Discov. 2008. PMID: 18404149 Review.

10

Discovery and optimization of a highly efficacious class of 5-aryl-2-aminopyridines as FMS-like tyrosine kinase 3 (FLT3) inhibitors.

Liu G, Abraham S, Liu X, Xu S, Rooks AM, Nepomuceno R, Dao A, Brigham D, Gitnick D, Insko DE, Gardner MF, Zarrinkar PP, Christopher R, Belli B, Armstrong RC, Holladay MW. Liu G, et al. Among authors: zarrinkar pp. Bioorg Med Chem Lett. 2015 Sep 1;25(17):3436-41. doi: 10.1016/j.bmcl.2015.07.023. Epub 2015 Jul 14. Bioorg Med Chem Lett. 2015. PMID: 26208887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page